Viferon gel user manual
- Viferon gel user manual
ATX code L03AB01
Pharmacotherapeutic group : antiviral immunomodulating agent.
Dosage form : gel for external use.
Form release : opaque homogeneous gel-like mass of white with a grayish tinge, aluminum tube, cardboard box.
Immunomodulating, antiviral, antiproliferative.
Active substances :
- Recombinant human α-2b interferon (36 IU).
Auxiliary components :
- Alpha-tocopherol acetate;
- Sodium tetraborate decahydrate;
- benzoic acid;
- Serum human albumin, 10%;
- sodium chloride;
- Sodium carmellose;
- Acid lemon monohydrate;
- 95% ethanol;
- purified water.
Viferon gel has antiviral, immunomodulatory and antiproliferative action. Suppresses the replication of viral nucleic acids. Strengthens the phagocytic activity of macrophages, increases the specific cytotoxicity to the cells of lymphocyte targets. Due to the antioxidants (citric and benzoic acids) and α-tocopherol acetate included in the preparation, the antiviral activity and immunomodulatory effect of interferon increases, which contributes to the increase of the effectiveness of the immune response of the organism to infectious agents.
Under the influence of the drug, the amount of locally formed IgA antibodies increases, which prevent the attachment and reproduction of pathogenic microorganisms and viruses on the mucous membranes of the upper respiratory tract.
Thanks to the gel basis, the prolonged action of the drug is provided.
Due to the fact that this drug is a drug for external use, the methods for finding out the pharmacokinetic processes in the blood, used at the present stage, are not sensitive enough.
Indications for use
- As a preparation of complex therapy of influenza, ARVI, complicated bacterial infections;
- Recurrent stenosing larengotraheobronchitis (in complex therapy);
- Recurrent herpesvirus infection (acute and exacerbation of chronic form) of cutaneous and mucous membranes, including those affecting the urogenital area;
- Herpetic cervicitis (in complex therapy);
- Prevention of influenza and ARVI;
- Prevention of recurrent stenosing laryngotraheobronchitis.
- Hypersensitivity or individual intolerance of the drug components.
In view of the very low absorption of the components of the drug, pregnancy and lactation are not contraindications to the use of the drug.
Dosing and Administration
In the treatment of diseases of the upper respiratory tract, the gel is applied to the pre-dried surface of the nasal mucosa or palatine tonsils 3-5 times a day, in the amount of 0.5 cm. A cotton swab or spatula is used for its application. The duration of therapy is 5 days, according to medical indications, the treatment course can be prolonged.
In order to prevent influenza and acute respiratory viral infection, it is recommended to apply Viferon gel on the mucosa in the same amount for 2-4 weeks, 2 times a day.
With recurrent stenosing laryngotrachlear bronchitis, the drug is used in conjunction with other drugs. It is recommended to apply it on the mucous membranes 5-7 days 5 times a day, and then, for 3 weeks - 3 times a day.
In order to prevent this pathology, the gel is used for 3-4 weeks 2 times a day, the therapeutic courses are repeated 2 times a year.
In the treatment of herpesvirus infection Viferon is recommended to start using when the first signs of the disease appear, or in the prodromal period. Gel, in the amount of 0.5 cm is applied to the affected area 3-5 times a day for 5-6 days. According to medical indications, the duration of the course increases until the disappearance of clinical symptoms.
In the treatment of herpetic cervicitis, the gel is applied to the cervix, previously cleaned of mucus, in an amount of 1 ml. The procedure should be carried out for 7 days 2 times a day. According to medical indications, the duration of the course is increased to 14 days.
When using the drug, it is possible to develop skin allergic reactions (itching, hives , skin hyperemia).
Viferon gel is perfectly combined with all antiviral, antibacterial, anti-inflammatory agents, as well as chemotherapy drugs used in the treatment of the diseases indicated in the indications.
Data on the overdose of the gel Viferon is not available.
Does not affect the ability to drive vehicles. During lactation it is not recommended to apply to the nipple and areola area.
Refers to non-prescription drugs.
Store in a dry place, protected from light, out of reach of children, at a temperature of 2-8 ° C.
Shelf life of the drug is 1 year from the date of production. After the expiry date indicated on the package, the drug should not be used.
Viferon gel price
The average price in pharmacies in Moscow is 150.00 rubles.
Viferon gel and taxes